Chimeric antigen receptor T-cell therapy and fludarabine precision dosing imperatives

Standard

Chimeric antigen receptor T-cell therapy and fludarabine precision dosing imperatives. / Wicha, Sebastian; Wansing, Eva-Maria A; Dadkhah, Adrin; Ayuk, Francis Ayuketang; Kröger, Nicolaus; Langebrake, Claudia.

in: BLOOD ADV, Jahrgang 8, Nr. 3, 13.02.2024, S. 797-798.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungKommentarForschung

Harvard

APA

Vancouver

Bibtex

@article{056b34fddeb2459bb5610162a95e6905,
title = "Chimeric antigen receptor T-cell therapy and fludarabine precision dosing imperatives",
author = "Sebastian Wicha and Wansing, {Eva-Maria A} and Adrin Dadkhah and Ayuk, {Francis Ayuketang} and Nicolaus Kr{\"o}ger and Claudia Langebrake",
note = "Commentary",
year = "2024",
month = feb,
day = "13",
doi = "10.1182/bloodadvances.2023012068",
language = "English",
volume = "8",
pages = "797--798",
journal = "BLOOD ADV",
issn = "2473-9529",
publisher = "Elsevier BV",
number = "3",

}

RIS

TY - JOUR

T1 - Chimeric antigen receptor T-cell therapy and fludarabine precision dosing imperatives

AU - Wicha, Sebastian

AU - Wansing, Eva-Maria A

AU - Dadkhah, Adrin

AU - Ayuk, Francis Ayuketang

AU - Kröger, Nicolaus

AU - Langebrake, Claudia

N1 - Commentary

PY - 2024/2/13

Y1 - 2024/2/13

U2 - 10.1182/bloodadvances.2023012068

DO - 10.1182/bloodadvances.2023012068

M3 - Comment/debate

C2 - 38191740

VL - 8

SP - 797

EP - 798

JO - BLOOD ADV

JF - BLOOD ADV

SN - 2473-9529

IS - 3

ER -